ASHPOfficial

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Hannah Post, education director at ASHP, as she interviews Angela Slampak-Cindric, director of the PGY2 critical care pharmacy residency program and coordinator for critical care and emergency medicine at Geisinger Medical Center, Sarah Gaffney, vice president of pharmacy services for HealthTrust Supply Chain - HCA Capital Division, and Michelle Allen, community hospital clinical pharmacist in Northern California, to discuss their upcoming session: Sleepy, Happy, Grumpy, Dopey, Sneezy & Bashful: Advice From the ICU Pharmacy Doc.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Acute kidney injury is a leading cause of morbidity and mortality in hospitalized patient which also confers higher costs of care from longer hospital stays and necessary management strategies. This podcast details the motivation to initiate a nephrotoxin stewardship program, the implementation frameworks operationalized to deploy the program, and preliminary results and future refinements to support growth of the program.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Seun Lagbenro, Kimberly Cuellar, and Thomas Peña, three pharmacy students at the University of Texas at Austin, College of Pharmacy. They share what inspires them to pursue a career in pharmacy and offer insights into the experiences of a pharmacy student.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides an overview of manufacturer copay cards, explaining eligibility limitations for commercially insured patients, how programs are funded and applied, and the variability in enrollment requirements and benefit structures. It also discusses how copay cards may extend beyond medication costs to cover administration fees and how they support health systems by improving access, adherence, and revenue cycle efficiency. The speakers clarify the differences between copay accumulators and maximizers, highlighting their financial and operational impacts on patients, pharmacies, and health systems.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As there are increasingly more restrictions on how specialty medications are acquired and administered, health systems are adapting by using new distribution models. In this episode, we discuss the complex world of pharmacy-provider integration. This podcast discusses real-world operations, as well as appropriate coverage determination and billing, for “clear bagging” medications for clinic administration. Join us to hear from three health systems about their journeys and lessons learned in managing efficient, successful clear bagging processes.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As pharmacy continues to evolve, collaboration remains essential to addressing many of the profession’s most pressing challenges. In this special National Pharmacy Week episode, ASHP Executive Vice President and CEO Sam Calabrese and American Pharmacists Association Executive Vice President and CEO Michael Hogue discuss how collaboration across the pharmacy profession can support pharmacy professionals, advance patient care, and strengthen the future of pharmacy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Hannah Post, education director at ASHP, as she interviews Diana Isaacs, endocrine clinical pharmacy specialist at Cleveland Clinic Diabetes Center, and Christie Schumacher, professor of pharmacy practice and director of the PGY2 Ambulatory Care Residency Program at Midwestern University College of Pharmacy, Downers Grove Campus, to discuss their upcoming session: The Incredible Incretins: Expanded Indications and the Latest Breakthroughs.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, participants share their own stories — the successes, missteps, and lessons they wish they'd known — while offering practical strategies to help pharmacists and pharmacy technicians navigate their first 90 days with confidence. They then explore how embracing continuous professional development can transform each career transition into an opportunity for lifelong growth and professional fulfillment.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This activity explores emerging evidence on the relationship between GLP-1 receptor agonists therapy and bone mineral density. As the use of these agents expands across chronic disease states, pharmacists must understand their potential impact on bone health to support comprehensive patient care and risk mitigation.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As artificial intelligence becomes embedded across health systems, pharmacy leaders face a new challenge: leading organizational change to seamlessly adopt and integrate it. Join pharmacy executives and innovation leaders as they discuss managing workforce expectations, establishing strong AI governance, measuring meaningful outcomes, and scaling successful initiatives to drive lasting value across the pharmacy enterprise.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Hannah Post, education director at ASHP, as she interviews Heidi Trinkman, advanced therapeutics program manager at Cook Children's Health Care System, Emilie Aschenbrenner, pharmacy program lead for cell and gene therapy and bone marrow transplant at Froedtert Hospital, and Wendy Galbraith, Clinical Associate Professor at the University of Oklahoma Health Sciences Center, to discuss their upcoming session: Transforming Care Through Next-Generation Therapeutics: Theranostics, Cell and Gene Therapies, and Pharmacogenomics.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a deep dive with the authors of the new ASHP Guidelines on Pharmacist Involvement in HIV Care, where we will unpack its contents. This episode discusses the evolving role of pharmacists in HIV prevention, treatment, and management, from expanding access to HIV testing and PrEP/PEP services to optimizing antiretroviral therapy and addressing social determinants of health. We’ll explore how pharmacists can improve patient outcomes and advocate for policy changes that deepen our impact. Tune in to learn what’s new, what’s next, and how these guidelines can transform HIV care across all practice settings.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Anthony Scott, director, pharmacy operations and account management at Cardinal Health, and Katherine Miller, senior director acute care pharmacy & clinical nutrition at The University of Kansas Health System, to discuss their upcoming session: Futurecasting Your Department: Strategic Succession Planning in an Era of Rapid Change.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Women experience changes in thrombotic and bleeding risk across every stage of life, yet these considerations are often underrecognized in antithrombotic management. This episode explores how antithrombotic stewardship can optimize care from menstruation through menopause, highlighting practical strategies for managing heavy menstrual bleeding, contraception, pregnancy considerations, perimenopause, and hormone therapy while balancing thrombosis and bleeding risks. Listeners will gain evidence-based approaches to individualized patient care, improve interdisciplinary collaboration, and identify stewardship opportunities to enhance safety, outcomes, and health equity for patients receiving anticoagulant and antithrombotic therapy.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Advocacy is a driving force behind our strategic priorities and this year’s Policy Week brought those priorities directly to Capitol Hill. ASHP Executive Vice President and CEO Sam Calabrese and Chief Advocacy Officer and Vice President of Government Relations Tom Kraus reflect on this year’s Policy Week, discussing the key policy priorities that shaped the week, conversations with lawmakers and congressional staff, and the momentum surrounding pharmacy’s advocacy priorities. From meaningful engagement on the Hill to the collective voice of our members, we’ll explore how Policy Week is helping turn our advocacy priorities into action.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses resources and offers support for residents that have experienced a co-resident’s departure from the residency program. Discussion will involve how to re-balance and carry the mental load if residents are expected to fill in the gap. Listeners will hear discussions from residency program directors and past residents that experienced the departure of a co-resident.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores medication access options for uninsured and underinsured patients, including manufacturer patient assistance programs, copay cards, nonprofit foundations, discount programs, and federal assistance. It also highlights how advanced pharmacy technicians lead medication access programs that improve adherence, reduce costs, streamline workflows, and drive measurable quality and financial outcomes.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Clinical trials in acute and emergency care settings may require immediate pharmacy support in the evenings, nights and weekends when staff with specialized expertise are not on site. In this episode, two experienced clinical research pharmacists highlight the challenges of after-hours investigational drug dispensing and detail practical strategies and creative techniques for managing these time-sensitive studies.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2026 Midyear Clinical Meeting and Exhibition, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews Thomas Johnson, vice president of diagnostic and therapeutic services at Avera Health, to discuss his upcoming session: From Overlooked to Approved: The Power of Clarity with C-Suite Resource Requests.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Respiratory Syncytial Virus (RSV) is the most common cause of bronchiolitis, the most common lower respiratory tract infection in infants less than 12 months old. The recent availability of a maternal vaccination and a neonatal/infant immunoglobulin injection provide the chance for a dramatic change in the rates of infection. Unfortunately, an increasing vaccination hesitancy in the United States threatens the potential of these efforts. After completing this episode, learners will be able to discuss the presentation and management of an infant with RSV and review the vaccination processes to prevent transmission of RSV.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.